Cart
sales@molnova.com
BTA-9881
CAS No. 1646857-24-0
BTA-9881( —— )
Catalog No. M34195 CAS No. 1646857-24-0
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 372 | In Stock |
|
| 10MG | 635 | In Stock |
|
| 25MG | 1387 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2483 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTA-9881
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
DescriptionBTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorRSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1646857-24-0
-
Formula Weight390.82
-
Molecular FormulaC21H15ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(N1[C@]2(C=3C(C(=O)N2CC1)=CC=NC3)C4=CC=C(Cl)C=C4)C=5C=CC=NC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
STAT3-IN-1
STAT3-IN-1 selective and orally active inhibitor of STAT3(in HT29 and MDA-MB 231 cells, with IC50 values of 1.82 μM and 2.14 μM , respectively), induces tumor apoptosis.
-
C188-9 (b)
A novel small-molecule STAT3 inhibitor with Ki of 12.4 nM; inhibits STAT3 binding to its pY-peptide ligand.
-
STAT3 inhibitor C188
A potent, selective STAT3 inhibitor that blocks STAT3 binding to its phosphopeptide ligand (IC50=20 uM).
